Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

377 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease.
Lescoat A, Lelong M, Jeljeli M, Piquet-Pellorce C, Morzadec C, Ballerie A, Jouneau S, Jego P, Vernhet L, Batteux F, Fardel O, Lecureur V. Lescoat A, et al. Among authors: lelong m. Biochem Pharmacol. 2020 Aug;178:114103. doi: 10.1016/j.bcp.2020.114103. Epub 2020 Jun 17. Biochem Pharmacol. 2020. PMID: 32562787 Free article.
Efferocytosis capacities of blood monocyte-derived macrophages in systemic sclerosis.
Ballerie A, Lescoat A, Augagneur Y, Lelong M, Morzadec C, Cazalets C, Jouneau S, Fardel O, Vernhet L, Jégo P, Lecureur V. Ballerie A, et al. Among authors: lelong m. Immunol Cell Biol. 2019 Mar;97(3):340-347. doi: 10.1111/imcb.12217. Epub 2018 Dec 13. Immunol Cell Biol. 2019. PMID: 30426551 Free article.
Effects of Ruxolitinib on fibrosis in preclinical models of systemic sclerosis.
Bellamri N, Lelong M, Joannes A, Le Tallec E, Jouneau S, Vernhet L, Lescoat A, Lecureur V. Bellamri N, et al. Among authors: lelong m. Int Immunopharmacol. 2023 Mar;116:109723. doi: 10.1016/j.intimp.2023.109723. Epub 2023 Jan 23. Int Immunopharmacol. 2023. PMID: 36696855 Free article.
Effects of different amosite preparations on macrophages, lung damages, and autoimmunity.
Lescoat A, Leinardi R, Pouxvielh K, Yakoub Y, Lelong M, Pochet A, Dumontet E, Bellamri N, Le Tallec E, Pavan C, Turci F, Paris C, Huaux F, Lecureur V. Lescoat A, et al. Among authors: lelong m. J Mol Med (Berl). 2024 Feb;102(2):197-211. doi: 10.1007/s00109-023-02401-9. Epub 2023 Nov 28. J Mol Med (Berl). 2024. PMID: 38015242
The risk of COVID-19 in IBD patients is increased by urban living and is not influenced by disease activity or intravenous biologics.
Lelong M, Josien R, Coste-Burel M, Rimbert M, Bressollette-Bodin C, Nancey S, Bouguen G, Allez M, Serrero M, Caillo L, Rouillon C, Blanc P, Laharie D, Olivier R, Peyrin-Biroulet L, Dib N, De Maissin A, Montuclard C, Trang-Poisson C, Vavasseur F, Gallot G, Berthome M, Braudeau C, Chevreuil J, Bourreille A, Le Berre C. Lelong M, et al. Front Immunol. 2023 Aug 28;14:1243898. doi: 10.3389/fimmu.2023.1243898. eCollection 2023. Front Immunol. 2023. PMID: 37701431 Free PMC article.
377 results